Biohaven Operating Income 2016-2022 | BHVN
Biohaven operating income from 2016 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Biohaven Annual Operating Income
(Millions of US $) |
| 2021 |
$-704 |
| 2020 |
$-645 |
| 2019 |
$-479 |
| 2018 |
$-225 |
| 2017 |
$-108 |
| 2016 |
$-61 |
| 2015 |
$-10 |
Biohaven Quarterly Operating Income
(Millions of US $) |
| 2022-09-30 |
$-68 |
| 2022-06-30 |
$-290 |
| 2022-03-31 |
$-54 |
| 2021-12-31 |
$-241 |
| 2021-09-30 |
$-55 |
| 2021-06-30 |
$-172 |
| 2021-03-31 |
$-236 |
| 2020-12-31 |
$-171 |
| 2020-09-30 |
$-163 |
| 2020-06-30 |
$-161 |
| 2020-03-31 |
$-151 |
| 2019-12-31 |
$-135 |
| 2019-09-30 |
$-90 |
| 2019-06-30 |
$-199 |
| 2019-03-31 |
$-54 |
| 2018-12-31 |
$-48 |
| 2018-09-30 |
$-55 |
| 2018-06-30 |
$-38 |
| 2018-03-31 |
$-83 |
| 2017-12-31 |
$-28 |
| 2017-09-30 |
$-40 |
| 2017-06-30 |
$-25 |
| 2017-03-31 |
$-14 |
| 2016-12-31 |
$-23 |
| 2016-09-30 |
$-28 |
| 2016-06-30 |
$-7 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.913B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
